期刊论文详细信息
Journal of Experimental & Clinical Cancer Research
New insights into the ambivalent role of YAP/TAZ in human cancers
Review
Liang Deng1  Mingli Huang1  Gengqiang Ling2  Yibo Guo3  Hailin Zou3  Juan Luo3  Tongyu Tong4  Peng Li5 
[1] Department of General Surgery, The Seventh Affiliated Hospital of Sun Yat-sen University, No. 628 Zhenyuan Road, 518107, Shenzhen, Guangdong, People’s Republic of China;Department of Neurosurgery, The Seventh Affiliated Hospital of Sun Yat-sen University, No. 628 Zhenyuan Road, 518107, Shenzhen, Guangdong, People’s Republic of China;Scientific Research Center, The Seventh Affiliated Hospital of Sun Yat-sen University, No. 628 Zhenyuan Road, 518107, Shenzhen, Guangdong, People’s Republic of China;Scientific Research Center, The Seventh Affiliated Hospital of Sun Yat-sen University, No. 628 Zhenyuan Road, 518107, Shenzhen, Guangdong, People’s Republic of China;Department of Urology, Pelvic Floor Disorders Center, The Seventh Affiliated Hospital of Sun Yat-sen University, No. 628 Zhenyuan Road, 518107, Shenzhen, Guangdong, People’s Republic of China;Scientific Research Center, The Seventh Affiliated Hospital of Sun Yat-sen University, No. 628 Zhenyuan Road, 518107, Shenzhen, Guangdong, People’s Republic of China;Guangdong Provincial Key Laboratory of Digestive Cancer Research, The Seventh Affiliated Hospital of Sun Yat-sen University, No. 628 Zhenyuan Road, 518107, Shenzhen, Guangdong, People’s Republic of China;
关键词: Hippo pathway;    YAP/TAZ;    Oncogene;    Tumor suppressor;    Targeted therapy;   
DOI  :  10.1186/s13046-023-02704-2
 received in 2023-01-17, accepted in 2023-05-10,  发布年份 2023
来源: Springer
PDF
【 摘 要 】

Hippo signaling was first identified in Drosophila as a key controller of organ size by regulating cell proliferation and anti-apoptosis. Subsequent studies have shown that this pathway is highly conserved in mammals, and its dysregulation is implicated in multiple events of cancer development and progression. Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ) (hereafter YAP/TAZ) are the downstream effectors of the Hippo pathway. YAP/TAZ overexpression or activation is sufficient to induce tumor initiation and progression, as well as recurrence and therapeutic resistance. However, there is growing evidence that YAP/TAZ also exert a tumor-suppressive function in a context-dependent manner. Therefore, caution should be taken when targeting Hippo signaling in clinical trials in the future. In this review article, we will first give an overview of YAP/TAZ and their oncogenic roles in various cancers and then systematically summarize the tumor-suppressive functions of YAP/TAZ in different contexts. Based on these findings, we will further discuss the clinical implications of YAP/TAZ-based tumor targeted therapy and potential future directions.Graphical Abstract

【 授权许可】

CC BY   
© The Author(s) 2023

【 预 览 】
附件列表
Files Size Format View
RO202308152462907ZK.pdf 2057KB PDF download
MediaObjects/12888_2023_4849_MOESM1_ESM.docx 17KB Other download
41116_2023_36_Article_IEq289.gif 1KB Image download
41116_2023_36_Article_IEq296.gif 1KB Image download
MediaObjects/12888_2023_4830_MOESM1_ESM.docx 36KB Other download
Fig. 2 243KB Image download
41116_2023_36_Article_IEq321.gif 1KB Image download
【 图 表 】

41116_2023_36_Article_IEq321.gif

Fig. 2

41116_2023_36_Article_IEq296.gif

41116_2023_36_Article_IEq289.gif

【 参考文献 】
  • [1]
  • [2]
  • [3]
  • [4]
  • [5]
  • [6]
  • [7]
  • [8]
  • [9]
  • [10]
  • [11]
  • [12]
  • [13]
  • [14]
  • [15]
  • [16]
  • [17]
  • [18]
  • [19]
  • [20]
  • [21]
  • [22]
  • [23]
  • [24]
  • [25]
  • [26]
  • [27]
  • [28]
  • [29]
  • [30]
  • [31]
  • [32]
  • [33]
  • [34]
  • [35]
  • [36]
  • [37]
  • [38]
  • [39]
  • [40]
  • [41]
  • [42]
  • [43]
  • [44]
  • [45]
  • [46]
  • [47]
  • [48]
  • [49]
  • [50]
  • [51]
  • [52]
  • [53]
  • [54]
  • [55]
  • [56]
  • [57]
  • [58]
  • [59]
  • [60]
  • [61]
  • [62]
  • [63]
  • [64]
  • [65]
  • [66]
  • [67]
  • [68]
  • [69]
  • [70]
  • [71]
  • [72]
  • [73]
  • [74]
  • [75]
  • [76]
  • [77]
  • [78]
  • [79]
  • [80]
  • [81]
  • [82]
  • [83]
  • [84]
  • [85]
  • [86]
  • [87]
  • [88]
  • [89]
  • [90]
  • [91]
  • [92]
  • [93]
  • [94]
  • [95]
  • [96]
  • [97]
  • [98]
  • [99]
  • [100]
  • [101]
  • [102]
  • [103]
  • [104]
  • [105]
  • [106]
  • [107]
  • [108]
  • [109]
  • [110]
  • [111]
  • [112]
  • [113]
  • [114]
  • [115]
  • [116]
  • [117]
  • [118]
  • [119]
  • [120]
  • [121]
  • [122]
  • [123]
  • [124]
  • [125]
  • [126]
  • [127]
  • [128]
  • [129]
  • [130]
  • [131]
  • [132]
  • [133]
  • [134]
  • [135]
  • [136]
  • [137]
  • [138]
  • [139]
  • [140]
  • [141]
  • [142]
  • [143]
  • [144]
  • [145]
  • [146]
  • [147]
  • [148]
  • [149]
  • [150]
  • [151]
  • [152]
  • [153]
  • [154]
  • [155]
  • [156]
  • [157]
  • [158]
  文献评价指标  
  下载次数:1次 浏览次数:0次